Abstract
Nanotechnology is an advancing field of biomedical science especially in drug delivery system. Nanoceria a part of nanotechnology will appear as an innovative drug delivery carrier in various therapies. The unique ability of nanoceria to switch its oxidation state between +3 and +4 makes it a potent therapeutic option for many diseases associated with oxidative stress, inflammation and also a potent drug delivery agent.
Description: In this review article, we focus the main drug delivery mechanisms (autoregeneration and radical scavenger) of nanoceria and its synthesis, characterization, toxicity; application with respect to reactive oxygen species (ROS) mediated disorders.Keywords: Nanoceria, cerium oxide nanoparticle (CNP), cytoprotective, reactive oxygen species (ROS), oxidative stress, novel carrier.
Graphical Abstract
Current Nanomedicine
Title:Nanoceria: A Novel Cytoprotective Drug Delivery Carrier
Volume: 7 Issue: 2
Author(s): Jawahar Natarajan*Sukumar Nagavishwakya
Affiliation:
- JSS College of Pharmacy, JSS University, Mysore - Pharmaceutics Ootacamund, Tamil Nadu,India
Keywords: Nanoceria, cerium oxide nanoparticle (CNP), cytoprotective, reactive oxygen species (ROS), oxidative stress, novel carrier.
Abstract: Nanotechnology is an advancing field of biomedical science especially in drug delivery system. Nanoceria a part of nanotechnology will appear as an innovative drug delivery carrier in various therapies. The unique ability of nanoceria to switch its oxidation state between +3 and +4 makes it a potent therapeutic option for many diseases associated with oxidative stress, inflammation and also a potent drug delivery agent.
Description: In this review article, we focus the main drug delivery mechanisms (autoregeneration and radical scavenger) of nanoceria and its synthesis, characterization, toxicity; application with respect to reactive oxygen species (ROS) mediated disorders.Export Options
About this article
Cite this article as:
Natarajan Jawahar*, Nagavishwakya Sukumar, Nanoceria: A Novel Cytoprotective Drug Delivery Carrier, Current Nanomedicine 2017; 7 (2) . https://dx.doi.org/10.2174/2468187307666170208104644
DOI https://dx.doi.org/10.2174/2468187307666170208104644 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Calcium Sensitizers in Cardiac Surgery: Who, When, How and Why?
Current Vascular Pharmacology Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists
CNS & Neurological Disorders - Drug Targets Editorial [Hot topic: Progress and Prospects of Human Pluripotent Stem Cell Research(Guest Editor: Chunhui Xu)]
Current Stem Cell Research & Therapy Functions of Ghrelin in Brain, Gut and Liver
CNS & Neurological Disorders - Drug Targets Reversal in Cognition Impairments, Cholinergic Dysfunction, and Cerebral Oxidative Stress Through the Modulation of Ryanodine Receptors (RyRs) and Cysteinyl Leukotriene-1 (CysLT1) Receptors
Current Neurovascular Research Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Survival and Migration of Pre-induced Adult Human Peripheral Blood Mononuclear Cells in Retinal Degeneration Slow (rds) Mice Three Months After Subretinal Transplantation
Current Stem Cell Research & Therapy Immunomodulatory Properties of Farnesoids: The New Steroids?
Current Medicinal Chemistry From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry Innovative Opioid Peptides and Biased Agonism: Novel Avenues for More Effective and Safer Analgesics to Treat Chronic Pain
Current Medicinal Chemistry Ischemic Tolerance Induced by Normobaric Hyperoxia and Evaluation of Group I and II Metabotropic Glutamate Receptors
Current Neurovascular Research Human Kallikrein 6 Cerebrospinal Levels are Elevated in Multiple Sclerosis
Current Drug Discovery Technologies The ERK 1 and 2 Pathway in the Nervous System: From Basic Aspects to Possible Clinical Applications in Pain and Visceral Dysfunction
Current Neuropharmacology Alternative Routes of Administration of the Neuroprotective Pituitary Adenylate Cyclase Activating Polypeptide
Current Pharmaceutical Design Why Is Homocysteine Toxic for the Nervous and Immune Systems?
Current Aging Science Motor Control in the Human Spinal Cord and the Repair of Cord Function
Current Pharmaceutical Design Regulation of Ingestive Behavior, the Upper Gastrointestinal Motility and Gastric Acid Secretion by Ghrelin in Mammals
Current Nutrition & Food Science Adenosine Receptor Ligands in Clinical Trials
Current Topics in Medicinal Chemistry Experimental Drugs for Neuropathic Pain
Current Neuropharmacology Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
Current Neuropharmacology